Taiwan FDA registration f480d9a5657d0ed1160ea2144cd153ef
“Abbott” XIENCE Skypoint Everolimus Eluting Coronary Stent System
TW: “雅培” 賽恩斯天際艾諾莉茉斯冠狀動脈塗藥支架系統
Taiwan·Risk Class 3·MD·ABBOTT VASCULAR·Registered Sep 04, 2023 – Sep 04, 2028ActiveRegistration details
- Analysis ID
- f480d9a5657d0ed1160ea2144cd153ef
- License Form
- Ministry of Health Medical Device Import No. 036600
- Customs Code
- DHA05603660002
Company information
- Manufacturer
- ABBOTT VASCULAR
- Manufacturer Country
- Ireland
- Authorized Representative
- Abbott Medical Taiwan Co.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E0001 Cardiovascular stents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Sep 04, 2023
- Expiry Date
- Sep 04, 2028
About this record
Access comprehensive regulatory information for “Abbott” XIENCE Skypoint Everolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number f480d9a5657d0ed1160ea2144cd153ef and manufactured by ABBOTT VASCULAR. The authorized representative in Taiwan is Abbott Medical Taiwan Co..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices